Dynamics of the Cytokine Response toMycobacterium ulceransduring Antibiotic Treatment forM. ulceransDisease (Buruli Ulcer) in Humans
- 1 January 2009
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 16 (1), 61-65
- https://doi.org/10.1128/cvi.00235-08
Abstract
We have studied the evolution of the gamma interferon (IFN-γ) and interleukin 10 (IL-10) responses afterMycobacterium ulceranssonicate stimulation of whole blood from patients with earlyM. ulceranslesions during treatment with rifampin and streptomycin for 8 weeks. Among the 26 patients, secretion of IFN-γ increased during treatment, with a significant increase at 4 weeks and a further increase after 8 weeks overall. The increase was more rapid in patients with large or ulcerative lesions, becoming significant by 4 weeks. For small lesions, there was only a minor increase, which did not reach significance. There was no significant change in the median IL-10 response during antibiotic therapy, and there was no inverse correlation between IFN-γ and IL-10 responses. These results demonstrate that an IFN-γ secretory response toM. ulceransdeveloped, independently of IL-10 secretion, in patients whoseM. ulceransdisease healed during antibiotic therapy.Keywords
This publication has 24 references indexed in Scilit:
- Promising Clinical Efficacy of Streptomycin-Rifampin Combination for Treatment of Buruli Ulcer ( Mycobacterium ulcerans Disease)Antimicrobial Agents and Chemotherapy, 2007
- Evidence for an Intramacrophage Growth Phase ofMycobacterium ulceransInfection and Immunity, 2007
- Cytokine Response to Antigen Stimulation of Whole Blood from Patients with Mycobacterium ulcerans Disease Compared to That from Patients with TuberculosisClinical and Vaccine Immunology, 2006
- Infection withMycobacterium ulceransInduces Persistent Inflammatory Responses in MiceInfection and Immunity, 2005
- Efficacy of the Combination Rifampin-Streptomycin in Preventing Growth of Mycobacterium ulcerans in Early Lesions of Buruli Ulcer in HumansAntimicrobial Agents and Chemotherapy, 2005
- Sensitivity of PCR Targeting the IS 2404 Insertion Sequence of Mycobacterium ulcerans in an Assay Using Punch Biopsy Specimens for Diagnosis of Buruli UlcerJournal of Clinical Microbiology, 2005
- Dynamics of cytokine generation in patients with active pulmonary tuberculosisCurrent Opinion in Infectious Diseases, 2003
- An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.The Journal of Experimental Medicine, 1993
- Disseminated tuberculosis in interferon gamma gene-disrupted mice.The Journal of Experimental Medicine, 1993
- A CONTROLLED TRIAL OF THE TREATMENT OF MYCOBACTERIUM ULCERANS INFECTION WITH CLOFAZIMINEThe Lancet, 1973